These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor. Kaminski DL; Andrus CH; German D; Deshpande YG Ann Surg; 1990 Oct; 212(4):455-61. PubMed ID: 2171443 [TBL] [Abstract][Full Text] [Related]
63. Glucocorticoid protection against PAF-acether toxicity in mice. Myers A; Ramey E; Ramwell P Br J Pharmacol; 1983 Jun; 79(2):595-8. PubMed ID: 6652344 [TBL] [Abstract][Full Text] [Related]
64. Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. Kruse-Elliott KT; Whorton AR; Olson NC Shock; 1998 Jan; 9(1):40-5. PubMed ID: 9466472 [TBL] [Abstract][Full Text] [Related]
67. Evidence against the involvement of a cytochrome P-450 mechanism in pulmonary hemodynamics in the newborn pig. Perreault T; De Marte J; Coceani F Can J Physiol Pharmacol; 1991 Oct; 69(10):1405-9. PubMed ID: 1777839 [TBL] [Abstract][Full Text] [Related]
68. Hemodynamic effects of prostaglandins and catecholamines in graded reduction of pulmonary flow during venoarterial bypass in awake goats. Takewa Y; Tatsumi E; Taenaka Y; Nishimura T; Nakamura M; Takano H; Kitamura S; Mizuguchi K; Taniguchi S ASAIO J; 1999; 45(1):79-82. PubMed ID: 9952013 [TBL] [Abstract][Full Text] [Related]
69. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Szebeni J; Fontana JL; Wassef NM; Mongan PD; Morse DS; Dobbins DE; Stahl GL; Bünger R; Alving CR Circulation; 1999 May; 99(17):2302-9. PubMed ID: 10226097 [TBL] [Abstract][Full Text] [Related]
70. A method to study pulmonary vascular response in the conscious newborn piglet. Coe JY; Olley PM; Hamilton F; Vanhelder T; Coceani F Can J Physiol Pharmacol; 1987 May; 65(5):785-90. PubMed ID: 3621040 [TBL] [Abstract][Full Text] [Related]
71. The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. Montrucchio G; Alloatti G; Mariano F; Meda E; Tetta C; Emanuelli G; Camussi G Agents Actions; 1987 Jun; 21(1-2):72-8. PubMed ID: 3115072 [TBL] [Abstract][Full Text] [Related]
72. Effect of platelet activating factor on the human nasal mucosa. Pipkorn U; Karlsson G; Bake B Allergy; 1984 Feb; 39(2):141-5. PubMed ID: 6703263 [TBL] [Abstract][Full Text] [Related]
73. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. Goldstein RE; Ezra D; Laurindo FR; Feuerstein GZ Pharmacol Res Commun; 1986 Aug; 18 Suppl():151-62. PubMed ID: 3774842 [No Abstract] [Full Text] [Related]
74. Leukotriene D4: a potent vasoconstrictor of the pulmonary and systemic circulations in the newborn lamb. Yokochi K; Olley PM; Sideris E; Hamilton F; Huhtanen D; Coceani F Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():211-4. PubMed ID: 6211953 [No Abstract] [Full Text] [Related]
75. The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein. Bell RL; Harris RR Clin Rev Allergy Immunol; 1999; 17(1-2):91-109. PubMed ID: 10436861 [No Abstract] [Full Text] [Related]